Fulcrum Therapeutics, Inc. (FULC) vs Rocket Pharmaceuticals, Inc. (RCKT)
Fulcrum Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Fulcrum Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. are of similar size ($300.8M and $288.8M). Across the 11 metrics below, Rocket Pharmaceuticals, Inc. leads on 6 and Fulcrum Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | FULC | RCKT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (32.38%) | (4.77%) | (57.72%) |
| Return on assets | (30.75%) | (4.09%) | (49.22%) |
| Return on invested capital | 0.00% | (114.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack